Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02672787 · ClinicalTrials.gov registry record · NA
A ED-based Intervention to Improve Antihypertensive Adherence
A NA study of Hypertension and Blood Pressure, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT02672787: Completed NA study of Hypertension and Blood Pressure, sponsored by Vanderbilt University.
NCT02672787 is a NA study of Hypertension and Blood Pressure that has completed, run by Vanderbilt University. The registered enrollment target is 220 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02672787, a NA study of Hypertension and Blood Pressure, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite great strides, hypertension remains an incredibly important disease and public health problem. This study addresses this critical need among ED patients, a unique population of patients who are (a) likely to benefit from an antihypertensive adherence intervention due to their high prevalence of uncontrolled blood pressure and poor adherence, and (b) at high risk for poor cardiovascular outcomes. The protocol provides for a multicomponent intervention bundle to be tested among ED patients. Successful clinic-based behavioral interventions generally target a combination of barriers to adherence; bundled interventions have shown success in a wide range of settings and diseases. In some cases, bundled components were necessary to achieve blood pressure benefit in a primary care setting; isolated educational efforts have had mixed success in the ED.
Primary Outcome
The primary outcome is change in Blood Pressure, measured by BPTru, one month after enrollment.
Conditions Studied
Interventions
- BEHAVIORAL ED-based behavioral intervention
- BEHAVIORAL ED usual care plus education
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT02672787 record still lists
NCT02672787 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which ED-based behavioral intervention is the first listed.
NCT02672787 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02672787 about?
NCT02672787 is a clinical study titled "A ED-based Intervention to Improve Antihypertensive Adherence". Despite great strides, hypertension remains an incredibly important disease and public health problem. This study addresses this critical need among ED patients, a unique population of patients who are (a) likely to benefit from an antihypertensive adherence intervention due to their high prevalence...
What is the current status of trial NCT02672787?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2016-02. Estimated completion is 2018-06.
What conditions does trial NCT02672787 study?
This clinical trial studies the following conditions: Hypertension, Blood Pressure, Hypertensive Emergency.
What interventions are being tested in trial NCT02672787?
The interventions under investigation include: ED-based behavioral intervention (BEHAVIORAL), ED usual care plus education (BEHAVIORAL).
Who is sponsoring clinical trial NCT02672787?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02672787 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02672787's enrollment target sits among peer trials
220 206th of 470 higher than 262 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia